These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 9589252

  • 21. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease.
    Genest JJ, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow MR.
    Arterioscler Thromb; 1991; 11(5):1129-36. PubMed ID: 1911700
    [Abstract] [Full Text] [Related]

  • 22. Hyperhomocyst(e)inemia induces multiorgan damage.
    Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC.
    Heart Vessels; 2000; 15(3):135-43. PubMed ID: 11289502
    [Abstract] [Full Text] [Related]

  • 23. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD.
    J Clin Invest; 1996 Jul 01; 98(1):24-9. PubMed ID: 8690798
    [Abstract] [Full Text] [Related]

  • 24. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.
    Stanger OH, Semmelrock HJ, Rehak P, Tiran B, Meinitzer A, Rigler B, Tiran A.
    Atherosclerosis; 2002 May 01; 162(1):157-62. PubMed ID: 11947909
    [Abstract] [Full Text] [Related]

  • 25. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG.
    Clin Sci (Lond); 2001 Feb 01; 100(2):161-7. PubMed ID: 11171285
    [Abstract] [Full Text] [Related]

  • 26. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
    von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schönfeld R, Köhler E, Assmann G.
    Arterioscler Thromb; 1994 Mar 01; 14(3):460-4. PubMed ID: 8123652
    [Abstract] [Full Text] [Related]

  • 27. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Stanger O, Weger M, Renner W, Konetschny R.
    Clin Chem Lab Med; 2001 Aug 01; 39(8):725-33. PubMed ID: 11592442
    [Abstract] [Full Text] [Related]

  • 28. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
    Yoo JH, Lee SC.
    Atherosclerosis; 2001 Oct 01; 158(2):425-30. PubMed ID: 11583722
    [Abstract] [Full Text] [Related]

  • 29. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
    Okumura K, Aso Y.
    Metabolism; 2003 Nov 01; 52(11):1517-22. PubMed ID: 14624417
    [Abstract] [Full Text] [Related]

  • 30. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC, Oka RK, Graf EE, Schmölzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP.
    Circulation; 2003 Aug 26; 108(8):933-8. PubMed ID: 12912818
    [Abstract] [Full Text] [Related]

  • 31. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
    Kang SS, Wong PW.
    Atherosclerosis; 1996 Jan 26; 119(2):135-8. PubMed ID: 8808490
    [Abstract] [Full Text] [Related]

  • 32. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
    Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P.
    Stroke; 1990 Apr 26; 21(4):572-6. PubMed ID: 2326839
    [Abstract] [Full Text] [Related]

  • 33. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
    Moghadasian MH, McManus BM, Frohlich JJ.
    Arch Intern Med; 1997 Nov 10; 157(20):2299-308. PubMed ID: 9361570
    [Abstract] [Full Text] [Related]

  • 34. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
    Sydow K, Schwedhelm E, Arakawa N, Bode-Böger SM, Tsikas D, Hornig B, Frölich JC, Böger RH.
    Cardiovasc Res; 2003 Jan 10; 57(1):244-52. PubMed ID: 12504835
    [Abstract] [Full Text] [Related]

  • 35. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S, Keller C, Kempe HP, Amiral J, Ziegler R, Ritz E, Bergis KH, Wahl P, Nawroth P.
    Vasa; 1996 Jan 10; 25(3):233-41. PubMed ID: 8795304
    [Abstract] [Full Text] [Related]

  • 36. High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage.
    Kario K, Duell PB, Matsuo T, Sakata T, Kato H, Shimada K, Miyata T.
    Atherosclerosis; 2001 Aug 10; 157(2):441-9. PubMed ID: 11472745
    [Abstract] [Full Text] [Related]

  • 37. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
    Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A.
    J Clin Endocrinol Metab; 2001 Apr 10; 86(4):1518-24. PubMed ID: 11297577
    [Abstract] [Full Text] [Related]

  • 38. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
    Taylor LM, DeFrang RD, Harris EJ, Porter JM.
    J Vasc Surg; 1991 Jan 10; 13(1):128-36. PubMed ID: 1987384
    [Abstract] [Full Text] [Related]

  • 39. Hyperhomocyst(e)inemia in chronic stable renal transplant patients.
    Machado DJ, Paula FJ, Sabbaga E, Ianhez LE.
    Rev Hosp Clin Fac Med Sao Paulo; 2000 Jan 10; 55(5):161-8. PubMed ID: 11175576
    [Abstract] [Full Text] [Related]

  • 40. Homocysteine and vascular dysfunction.
    Lentz SR.
    Life Sci; 1997 Jan 10; 61(13):1205-15. PubMed ID: 9324062
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.